OmniaBio
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing... Read more
Org chart
Teams
Offices
STEMCELL Technologies
14 followers
REVOLUTION Medicines
19 followers
Freenome
10 followers
BillionToOne
8 followers
C4 Therapeutics
8 followers
Biocytogen
5 followers
Plasmidsaurus
2 followers
Vow
3 followers
Bill & Melinda Gates Medical Research Institute
7 followers
CTC Analytics AG
1 follower
Avidity
4 followers
Worldwide Clinical Trials
19 followers